Partner organisation:
Training for Safe-by-design aspects, translational safety, regulatory aspects in the nanotech field, networking and governance.
Expertise in stem cell technologies, cell differentiation, cryopreservation, reproductive technologies, molecular techniques, genetic engineering, assay development; industrial level quality control and new business development.
S. M. Discovery Group (SMDG) is an SME with innovative technology platforms focused on delivering therapies for debilitating diseases including neurological disorders like Alzheimer's disease, Parkinson's disease and Huntinton's disease.
The company has created a library of novel engineered nanoparticles for targeted delivery of nucleic acid therapies for gene therapy. SMDG also partners with investigators from across Europe.
ETH ZURICH - MACROMOLECULAR ENGINEERING LABORATORY
Research in the Macromolecular Engineering Laboratory at ETH Zurich focuses on the development of complex material structures and chemistries for biomedical applications.
By studying the fundamental processes of biology and materials science, our aim is to produce tangible technologies with clinical and societal impact in the fields of regenerative medicine, drug delivery and biomedical diagnostics.
